Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities ALNY - Alnylam Pharmaceuticals, Inc.
-117 M
LAST VALUE
-30.00%
2 YEAR CAGR
22.49%
5 YEAR CAGR
14.33%
10 YEAR CAGR